Back to Companies
Nasus Pharma Ltd
NSRXNYSECIK: 0002029039
Nasus Pharma Ltd (NSRX) shows 13 recent insider filings from 9 insiders, with all of them on the buy side. With $61.8K in purchases and $0 in sales, the recent tape is heavily weighted toward buying (a net purchase of $61.8K). Teleman Dan Benjamin (Chief Executive Officer, Director) is the most active by dollar volume, and the single largest transaction was $30.6K by Teleman Dan Benjamin. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$61.8K
Purchases
$61.8K
Sales
$0
Unique Insiders
9
Recent Insider Trades
13 loaded
| Jul 31 | NSRX Nasus Pharma Ltd | O'Grady Brendan P. | Chief Executive Officer, Director | Other | $0 |
| Jul 29 | NSRX Nasus Pharma Ltd | Teleman Dan Benjamin | Chief Executive Officer, Director | Other | $0 |
| Jun 22 | NSRX Nasus Pharma Ltd | Teleman Dan Benjamin | Chief Executive Officer, Director | Buy | $20.3K |
| Apr 22 | NSRX Nasus Pharma Ltd | Teleman Dan Benjamin | Chief Executive Officer, Director | Buy | $10.9K |
| Apr 1 | NSRX Nasus Pharma Ltd | Teleman Dan Benjamin | Chief Executive Officer, Director | Buy | $30.6K |
| Mar 27 | NSRX Nasus Pharma Ltd | Silberman David | Director | Other | $0 |
| Mar 27 | NSRX Nasus Pharma Ltd | Israel Isaac | Director | Other | $0 |
| Mar 27 | NSRX Nasus Pharma Ltd | Shacham Sharon | Director | Other | $0 |
| Mar 27 | NSRX Nasus Pharma Ltd | Gilboa Udi | Insider | Other | $0 |
| Mar 27 | NSRX Nasus Pharma Ltd | Megiddo Dalia | Chief Development Officer, Director | Other | $0 |
| Mar 27 | NSRX Nasus Pharma Ltd | Hershman Ronnie | Director | Other | $0 |
| Mar 27 | NSRX Nasus Pharma Ltd | Teleman Dan Benjamin | Chief Executive Officer, Director | Other | $0 |
| Mar 27 | NSRX Nasus Pharma Ltd | Rubin Eyal | Chief Financial Officer | Other | $0 |
13 filings